Drug intelligence / Profile preview

Atriplex wrightii pollen

Development stage
Unknown
Lead developer
Greer Laboratories
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Percutaneous, Intradermal, Subcutaneous
01

Overview

Atriplex wrightii pollen is a non-standardized allergenic extract derived from the pollen of the Atriplex wrightii plant, also known as Wright's saltbush or annual saltbush. [2, 7] Manufactured by Greer Laboratories, Inc. (a subsidiary of Stallergenes Greer), the extract is used for both the diagnosis and treatment of allergies specific to this pollen. [3, 4, 6] For diagnosis, it is applied via percutaneous (prick) or intradermal skin tests to confirm sensitivity. [4] For treatment, it is administered as subcutaneous immunotherapy (allergy shots) to desensitize the immune system and reduce allergic symptoms in patients with a confirmed allergy. [4, 14, 15] The therapy works by repeatedly exposing the patient to the allergen to induce immunologic tolerance. [14, 15]

Other names
Annual Saltbush pollenWright's saltbush pollenWright saltbush pollen
02

Targets

A. annua-specific IgE (Artemisia annua-specific immunoglobulin E)mAChR (Muscarinic acetylcholine receptors)

Beyond the preview

Go deeper on Atriplex wrightii pollen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Atriplex wrightii pollen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call